| Name | Title | Contact Details |
|---|
Every company has a mission. Whats ours? To empower every person and every organization to achieve more. We believe technology can and should be a force for good and that meaningful innovation contributes to a brighter world in the future and today. Our culture doesnt just encourage curiosity; it embraces it. Each day we make progress together by showing up as our authentic selves. We show up with a learn-it-all mentality. We show up cheering on others, knowing their success doesnt diminish our own. We show up every day open to learning our own biases, changing our behavior, and inviting in differences. Because impact matters. Microsoft operates in 190 countries and is made up of more than 220,000 passionate employees worldwide.
Pura is a smart fragrance diffuser that allows you to control your favorite scents from the convenience of your phone. Save your fragrance with custom scheduling, geofencing, and adjustable scent intensity to refine any house into your luxurious home.
Capitol Securities is a privately owned full service retail brokerage group founded in 1981 and headquartered in Richmond, Virginia. Capitol has more than 200 investment professionals serving approximately 18,000 accounts in multiple locations throughout the United States, with total client assets of approximately $4 billion. With a goal of helping create financial stability and security for our clients through a balanced approach to investing, we have earned a reputation for excellence in our industry for over 25 years.
The Rett Syndrome Research Trust (RSRT) was launched in 2008 with a singular goal: to drive the development of treatments and cures for Rett Syndrome and related MECP2 disorders. As one of the few neurological disorders to demonstrate dramatic symptom reversal in the lab, Rett Syndrome has captured the attention of the world`s premiere university and pharmaceutical industry scientists. RSRT is operating at the nexus of this activity, leading and advancing the research agenda. By funding the most Rett research worldwide, $66 million since 2008, we strive to put ourselves out of business as soon as possible.